ArticleAddictive behaviors2022
Substance, use in relation to COVID-19: A scoping review.
Article in Addictive behaviors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 61 citations in OpenAlex.
- Using Routinely Collected Data From the Network of Alcohol and Other Drugs Agencies Database to Evaluate the Impact of COVID-19 Lockdowns on Trends in Service Delivery in Outpatient Non-Government Alcohol and Other Drug Treatment Services.Alcohol, clinical & experimental research · 2026Observational
- The Impact of the COVID-19 Pandemic on the Care of Pregnant Women with a Focus on Those who Use Substances: Lessons for the Future.Disaster medicine and public health preparedness · 2025Article
- Large-Scale Deep Learning-Enabled Infodemiological Analysis of Substance Use Patterns on Social Media: Insights From the COVID-19 Pandemic.JMIR infodemiology · 2025Article
- Representative national survey on drug use during the COVID-19 stay-at-home order in the USA.BMJ open · 2025Article
- Impact of the COVID-19-Related Lockdown on Psychoactive Substance Consumption and Mental Health in Morocco.Ethiopian journal of health sciences · 2025Article
- Family-Centered Model and mHealth Through Early Intervention in Rural Populations: A Quasi-Experimental Study.Children (Basel, Switzerland) · 2025Article
- Beyond death counts: how COVID-19 affected excess mortality and productive life-years lost across 28 European states, 2020-2023.Frontiers in public health · 2025Article
- The Association between Social Contact Frequency and Intimate Partner Violence among Patients with Comorbid Substance Use and Mental Health Disorders during COVID-19.Journal of aggression, maltreatment & trauma · 2025Article
- COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration.AIDS and behavior · 2024Article
- Differences in the Rates of Diagnoses of Mental and Behavioral Disorders Due to Psychoactive Substance Use by Sex and Age during Pre-Pandemic and COVID-19 Pandemic Periods in Kazakhstan.Healthcare (Basel, Switzerland) · 2024Article
- Changes in smoking due to COVID-19 pandemic among persons of migrant origin compared with the general population: a population-based study.Scandinavian journal of public health · 2024Article
- Alcohol and Substance Use Among the Working Age Population: A Nationwide Study of Fall-Related Emergency Department Visits.Journal of studies on alcohol and drugs · 2024Article
- Examining enduring effects of COVID-19 on college students' internalizing and externalizing problems: A four-year longitudinal analysis.Journal of affective disorders · 2024Article
- Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.Annals of medicine · 2023Article
- HIV Prevention and Care Among Black Cisgender Sexual Minority Men and Transgender Women: Protocol for an HIV Status-Neutral Cohort Study Using an Observational-Implementation Hybrid Approach.JMIR research protocols · 2023Article
- Substance use patterns among a global sample of transgender and non-binary people during the COVID-19 pandemic.BMC global and public health · 2023Article
- Correlates of COVID-19 vaccine uptake among U.S. College students.Preventive medicine reports · 2023Article
- Has interest in smoking cessation declined during the COVID-19 pandemic?Perspectives in public health · 2023Article
- No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users.Journal of cannabis research · 2023Article
- Scale Development for COVID-19 Vaccine Hesitancy by Integration of Socio-Demographic and Psychological Factors.Vaccines · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 7 institutions in 4 countries.
Funding
Abstract
backgroundWe conducted a scoping review focused on various forms of substance use amid the pandemic, looking at both the impact of substance use on COVID-19 infection, severity, and vaccine uptake, as well as the impact that COVID-19 has had on substance use treatment and rates.
methodsA scoping review, compiling both peer-reviewed and grey literature, focusing on substance use and COVID-19 was conducted on September 15, 2020 and again in April 15, 2021 to capture any new studies. Three bibliographic databases (Web of Science Core Collection, Embase, PubMed) and several preprint servers (EuropePMC, bioRxiv, medRxiv, F1000, PeerJ Preprints, PsyArXiv, Research Square) were searched. We included English language original studies only.
resultsOf 1564 articles screened in the abstract and title screening phase, we included 111 research studies (peer-reviewed: 98, grey literature: 13) that met inclusion criteria. There was limited research on substance use other than those involving tobacco or alcohol. We noted that individuals engaging in substance use had increased risk for COVID-19 severity, and Black Americans with COVID-19 and who engaged in substance use had worse outcomes than white Americans. There were issues with treatment provision earlier in the pandemic, but increased use of telehealth as the pandemic progressed. COVID-19 anxiety was associated with increased substance use.
conclusionsOur scoping review of studies to date during COVID-19 uncovered notable research gaps namely the need for research efforts on vaccines, COVID-19 concerns such as anxiety and worry, and low- to middle-income countries (LMICs) and under-researched topics within substance use, and to explore the use of qualitative techniques and interventions where appropriate. We also noted that clinicians can screen and treat individuals exhibiting substance use to mitigate effects of the pandemic.
fundingStudy was funded by the Institution for Social and Policy Studies, Yale University and The Horowitz Foundation for Social Policy. DH was funded by a NIDA grant (R01DA048860). The funding body had no role in the design, analysis, or interpretation of the data in the study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.